+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cold-chain Pharma Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5666010
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cold-chain pharmaceutical market is transforming rapidly, demanding resilient logistics, advanced compliance, and patient-centric delivery. Modern supply chains must maintain therapy integrity and traceability while adapting to evolving regulations and fragmented global distribution patterns.

Market Snapshot: Cold-Chain Pharma Market Growth and Outlook

In 2025, the cold-chain pharmaceutical market reached USD 16.78 billion, expanding to USD 18.28 billion by 2026. Projected to grow at a CAGR of 9.39%, the market is set to achieve USD 31.47 billion by 2032. Rising adoption of biologics, cell and gene therapies, and innovative vaccine platforms continues to drive demand for robust temperature-controlled logistics across regions.

Scope & Segmentation

  • Product Types: Biologics (monoclonal antibodies, plasma-derived therapeutics, recombinant proteins), cell and gene therapies (allogeneic, autologous), vaccines, insulins, blood and plasma products, and investigational clinical trial materials.
  • Packaging Solutions: Active packaging, passive packaging, modular/validated solutions, cryo packaging, and dry shippers, each supporting a diverse range of temperature requirements.
  • Equipment Categories: Cryogenic freezers, LN2 tanks, ultra-low temperature (ULT) freezers, air cargo containers, cold rooms, and portable coolers.
  • Service Models: Clinical trial logistics, compliance and quality services, warehousing and storage, transportation, last-mile and direct-to-patient delivery.
  • Applications: Clinical trials, commercial distribution, decentralized fulfillment, hospitals, CMOs, vaccination campaigns.
  • End-Users: Manufacturers, CROs, CDMOs, third-party logistics providers, specialty pharmacies, healthcare networks.
  • Geographies: Americas, Europe, Middle East & Africa, Asia-Pacific—each with distinct regulatory, infrastructure, and distribution landscapes.

Key Takeaways

  • End-to-end traceability and compliance are essential for maintaining product quality while managing growing complexity across cold-chain networks.
  • Product innovation and the rise of single-patient therapies are prompting new requirements for qualification protocols, packaging solutions, and chain-of-identity controls.
  • Modern packaging and equipment technologies provide both operational flexibility and scalable solutions for variable demand and emerging therapy classes.
  • Strategic partnerships between manufacturers, CMOs, and logistics providers are strengthening network resilience, compliance, and rapid-response capabilities.
  • Integrated digital temperature monitoring, robust lane validation, and enhanced workforce training are critical to minimizing risk and preserving regulatory alignment.

Tariff Impact: Navigating 2025 Regulatory Changes

The United States’ 2025 tariff adjustments present new sourcing and operational challenges for global cold-chain networks. Increased landed costs for imported storage and transport equipment—as well as packaging components—are causing firms to reconsider supply chain structures. Procurement leaders are weighing nearshoring options, revisiting supplier agreements, and updating scenario-based plans to mitigate the impact on cost and operational continuity. Collaboration among manufacturers, third-party logistics providers, and regulatory teams is intensifying to maintain readiness for clinical trials and product rollouts under evolving tariff regimes.

Methodology & Data Sources

This analysis leverages primary interviews with industry experts, regulatory validation, and scenario-based assessments. Insights are grounded in a structured review of product, packaging, and equipment categories, supported by peer-reviewed literature on compliance and best practices.

Why This Report Matters

  • Equips decision-makers to align cold-chain strategies with emerging regulatory, product, and regional requirements.
  • Enables proactive investments in modular equipment, validated packaging, and integrated services to enhance resilience and cost-efficiency.
  • Supports scenario-based planning to respond efficiently to market shifts, operational disruptions, or regulatory changes.

Conclusion

Adaptive network design, validation-driven processes, and collaborative partnerships are crucial for sustaining product integrity and patient access. Organizations prioritizing integrated capabilities will effectively navigate the increasingly intricate landscape of cold-chain pharmaceutical distribution.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cold-chain Pharma Market, by Product Type
8.1. Biologics
8.1.1. Monoclonal Antibodies
8.1.2. Plasma-Derived Therapeutics
8.1.3. Recombinant Proteins & Enzymes
8.2. Blood & Plasma Products
8.2.1. Coagulation Factors
8.2.2. Immunoglobulins
8.3. Cell & Gene Therapies
8.3.1. Allogeneic Cell Therapies
8.3.2. Autologous Cell Therapies
8.3.3. Gene Therapies
8.4. Clinical Trial Materials
8.4.1. Ancillaries & Kits
8.4.2. Investigational Medicinal Products
8.5. Insulins & Hormones
8.5.1. GLP-1 & Other Peptide Hormones
8.5.2. Insulin
8.6. Specialty Pharmaceuticals
8.6.1. Fertility & Reproductive Medicines
8.6.2. Specialty Injectables
8.7. Vaccines
8.7.1. Pandemic & Emerging Vaccines
8.7.1.1. mRNA Vaccines
8.7.1.2. Viral Vector Vaccines
8.7.2. Routine Immunization Vaccines
8.7.3. Travel & Specialty Vaccines
9. Cold-chain Pharma Market, by Packaging Type
9.1. Active Packaging
9.2. Passive Packaging
10. Cold-chain Pharma Market, by Temperature Range
10.1. Cryogenic (= -150 °C)
10.1.1. Cryo Packaging
10.1.2. Dry Shipper Transport
10.1.3. LN2 Vapor Storage
10.2. Frozen (-20 To -40 °C)
10.2.1. Packaging
10.2.2. Storage
10.2.3. Transportation
10.3. Refrigerated (2-8 °C)
10.3.1. Packaging
10.3.2. Storage
10.3.3. Transportation
10.4. Ultra-Low (-60 To -86 °C)
10.4.1. Packaging
10.4.2. Storage
10.4.3. Transportation
11. Cold-chain Pharma Market, by Equipment
11.1. Storage Equipment
11.1.1. Cold Rooms & Warehouses
11.1.2. Cryogenic Freezers & LN2 Tanks
11.1.3. Freezers (-20 °C Class)
11.1.4. Pharmaceutical Refrigerators (2-8 °C)
11.1.5. ULT Freezers (-80 °C Class)
11.2. Transport Equipment
11.2.1. Air Cargo Containers (ULDs)
11.2.2. Last-Mile Portable Coolers
11.2.3. Ocean Reefer Containers
11.2.4. Reefer Trucks & Vans
12. Cold-chain Pharma Market, by Service Type
12.1. Clinical Trial Logistics
12.1.1. Ancillary Management
12.1.2. Direct-To-Patient Services
12.1.3. Site Supply And Returns
12.2. Compliance & Quality
12.2.1. Audits & GDP Training
12.2.2. Lane Validation & Risk Assessment
12.2.3. Qualification (IQ/OQ/PQ)
12.3. Storage & Warehousing
12.3.1. Cryogenic Storage
12.3.2. Long-Term GMP Storage
12.4. Transportation
12.4.1. First-Mile Pickup
12.4.2. Last-Mile Delivery
12.4.3. Line-Haul Transport
12.4.4. Reverse Logistics & Returns
13. Cold-chain Pharma Market, by Application
13.1. Clinical Trials
13.2. Commercial Distribution
13.3. Direct-To-Patient/Home Delivery
13.4. Humanitarian & NGO Supply
13.5. Specialty Pharmacy Fulfillment
13.6. Vaccination Campaigns
14. Cold-chain Pharma Market, by End User
14.1. Blood Banks & Plasma Centers
14.2. Clinical Trial Sites & Depots
14.3. CMOs & CDMOs
14.4. CROs
14.5. Hospitals & Clinics
14.6. Pharma & Biotech Manufacturers
14.6.1. Emerging Biotech
14.6.2. Large Pharmaceutical Companies
14.7. Retail & Specialty Pharmacies
14.8. Vaccination Centers & Public Health Agencies
15. Cold-chain Pharma Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Cold-chain Pharma Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Cold-chain Pharma Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Cold-chain Pharma Market
19. China Cold-chain Pharma Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Americold Realty Trust, Inc.
20.6. AmerisourceBergen Corporation
20.7. BioCold Technologies S.A.S
20.8. C.H. Robinson Worldwide, Inc.
20.9. Catalent, Inc.
20.10. Clinigen Group PLC
20.11. Conestoga Cold Storage Ltd.
20.12. Continental AG
20.13. CWT Ltd.
20.14. DB Schenker
20.15. DHL International GmbH
20.16. DSV A/S
20.17. Emergent Cold LatAm Management LLC
20.18. FedEx Corporation
20.19. FreezPak Logistics
20.20. HCL Technologies Limited
20.21. Helapet ltd.
20.22. Interstate Cold Storage, Inc.
20.23. JWD InfoLogistics Public Co. Ltd.
20.24. Keppel Telecommunications & Transportation Ltd,
20.25. Kerry Logistics Network Limited by SF Holding Co., Ltd.
20.26. Kuehne + Nagel Management AG
20.27. Lineage, Inc.
20.28. Mærsk A/S
20.29. NewCold Coöperatief UA
20.30. OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
20.31. SCG Logistics Management Co Ltd.
20.32. Tiong Nam Logistics Holdings Berhad
20.33. United Parcel Service, Inc.
20.34. Ych Group
20.35. Yusen Logistics Group
List of Figures
FIGURE 1. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL COLD-CHAIN PHARMA MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL COLD-CHAIN PHARMA MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY EQUIPMENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA COLD-CHAIN PHARMA MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PLASMA-DERIVED THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PLASMA-DERIVED THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PLASMA-DERIVED THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY RECOMBINANT PROTEINS & ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY RECOMBINANT PROTEINS & ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY RECOMBINANT PROTEINS & ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BLOOD & PLASMA PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BLOOD & PLASMA PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BLOOD & PLASMA PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BLOOD & PLASMA PRODUCTS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COAGULATION FACTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COAGULATION FACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY IMMUNOGLOBULINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY IMMUNOGLOBULINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CELL & GENE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CELL & GENE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CELL & GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ALLOGENEIC CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ALLOGENEIC CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ALLOGENEIC CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AUTOLOGOUS CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AUTOLOGOUS CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AUTOLOGOUS CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY GENE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY GENE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL MATERIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ANCILLARIES & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ANCILLARIES & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ANCILLARIES & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY INVESTIGATIONAL MEDICINAL PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY INVESTIGATIONAL MEDICINAL PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY INVESTIGATIONAL MEDICINAL PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY INSULINS & HORMONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY INSULINS & HORMONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY INSULINS & HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY INSULINS & HORMONES, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY GLP-1 & OTHER PEPTIDE HORMONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY GLP-1 & OTHER PEPTIDE HORMONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY GLP-1 & OTHER PEPTIDE HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY INSULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY INSULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY INSULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FERTILITY & REPRODUCTIVE MEDICINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FERTILITY & REPRODUCTIVE MEDICINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FERTILITY & REPRODUCTIVE MEDICINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PANDEMIC & EMERGING VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PANDEMIC & EMERGING VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PANDEMIC & EMERGING VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PANDEMIC & EMERGING VACCINES, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY MRNA VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY MRNA VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY MRNA VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VIRAL VECTOR VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VIRAL VECTOR VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ROUTINE IMMUNIZATION VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ROUTINE IMMUNIZATION VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ROUTINE IMMUNIZATION VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRAVEL & SPECIALTY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRAVEL & SPECIALTY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRAVEL & SPECIALTY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ACTIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ACTIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PASSIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PASSIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC (= -150 °C), BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC (= -150 °C), BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC (= -150 °C), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC (= -150 °C), 2018-2032 (USD MILLION)
TABLE 101. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYO PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYO PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYO PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY DRY SHIPPER TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY DRY SHIPPER TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY DRY SHIPPER TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LN2 VAPOR STORAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LN2 VAPOR STORAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LN2 VAPOR STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FROZEN (-20 TO -40 °C), BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FROZEN (-20 TO -40 °C), BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FROZEN (-20 TO -40 °C), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FROZEN (-20 TO -40 °C), 2018-2032 (USD MILLION)
TABLE 114. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED (2-8 °C), BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED (2-8 °C), BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED (2-8 °C), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED (2-8 °C), 2018-2032 (USD MILLION)
TABLE 127. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULTRA-LOW (-60 TO -86 °C), BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULTRA-LOW (-60 TO -86 °C), BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULTRA-LOW (-60 TO -86 °C), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULTRA-LOW (-60 TO -86 °C), 2018-2032 (USD MILLION)
TABLE 140. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COLD ROOMS & WAREHOUSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COLD ROOMS & WAREHOUSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COLD ROOMS & WAREHOUSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC FREEZERS & LN2 TANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC FREEZERS & LN2 TANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC FREEZERS & LN2 TANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FREEZERS (-20 °C CLASS), BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FREEZERS (-20 °C CLASS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FREEZERS (-20 °C CLASS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMACEUTICAL REFRIGERATORS (2-8 °C), BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMACEUTICAL REFRIGERATORS (2-8 °C), BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMACEUTICAL REFRIGERATORS (2-8 °C), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULT FREEZERS (-80 °C CLASS), BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULT FREEZERS (-80 °C CLASS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULT FREEZERS (-80 °C CLASS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORT EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORT EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORT EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORT EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AIR CARGO CONTAINERS (ULDS), BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AIR CARGO CONTAINERS (ULDS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AIR CARGO CONTAINERS (ULDS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LAST-MILE PORTABLE COOLERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LAST-MILE PORTABLE COOLERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LAST-MILE PORTABLE COOLERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY OCEAN REEFER CONTAINERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY OCEAN REEFER CONTAINERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY OCEAN REEFER CONTAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REEFER TRUCKS & VANS, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REEFER TRUCKS & VANS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REEFER TRUCKS & VANS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL LOGISTICS, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ANCILLARY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ANCILLARY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ANCILLARY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY DIRECT-TO-PATIENT SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY DIRECT-TO-PATIENT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY DIRECT-TO-PATIENT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SITE SUPPLY AND RETURNS, BY REGION, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SITE SUPPLY AND RETURNS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SITE SUPPLY AND RETURNS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COMPLIANCE & QUALITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COMPLIANCE & QUALITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COMPLIANCE & QUALITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COMPLIANCE & QUALITY, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AUDITS & GDP TRAINING, BY REGION, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AUDITS & GDP TRAINING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AUDITS & GDP TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LANE VALIDATION & RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LANE VALIDATION & RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LANE VALIDATION & RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY QUALIFICATION (IQ/OQ/PQ), BY REGION, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY QUALIFICATION (IQ/OQ/PQ), BY GROUP, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY QUALIFICATION (IQ/OQ/PQ), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE & WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE & WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE & WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY STORAGE & WAREHOUSING, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC STORAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC STORAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LONG-TERM GMP STORAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LONG-TERM GMP STORAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LONG-TERM GMP STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2032 (USD MILLION)
TABLE 226. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FIRST-MILE PICKUP, BY REGION, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FIRST-MILE PICKUP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FIRST-MILE PICKUP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LAST-MILE DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LAST-MILE DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LAST-MILE DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LINE-HAUL TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LINE-HAUL TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LINE-HAUL TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REVERSE LOGISTICS & RETURNS, BY REGION, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REVERSE LOGISTICS & RETURNS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REVERSE LOGISTICS & RETURNS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 241. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COMMERCIAL DISTRIBUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COMMERCIAL DISTRIBUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 244. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COMMERCIAL DISTRIBUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY DIRECT-TO-PATIENT/HOME DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY DIRECT-TO-PATIENT/HOME DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 247. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY DIRECT-TO-PATIENT/HOME DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY HUMANITARIAN & NGO SUPPLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY HUMANITARIAN & NGO SUPPLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 250. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY HUMANITARIAN & NGO SUPPLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY PHARMACY FULFILLMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 252. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY PHARMACY FULFILLMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 253. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY PHARMACY FULFILLMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 254. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VACCINATION CAMPAIGNS, BY REGION, 2018-2032 (USD MILLION)
TABLE 255. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VACCINATION CAMPAIGNS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 256. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VACCINATION CAMPAIGNS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BLOOD BANKS & PLASMA CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 259. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BLOOD BANKS & PLASMA CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 260. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BLOOD BANKS & PLASMA CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL SITES & DEPOTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 262. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL SITES & DEPOTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 263. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL SITES & DEPOTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 264. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CMOS & CDMOS, BY REGION, 2018-2032 (USD MILLION)
TABLE 265. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CMOS & CDMOS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 266. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CMOS & CDMOS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CROS, BY REGION, 2018-2032 (USD MILLION)
TABLE 268. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CROS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 269. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY CROS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 271. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 272. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 273. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA & BIOTECH MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 274. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA & BIOTECH MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 275. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA & BIOTECH MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 276. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA & BIOTECH MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 277. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY EMERGING BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 278. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY EMERGING BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 279. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY EMERGING BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 281. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 282. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY RETAIL & SPECIALTY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 284. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY RETAIL & SPECIALTY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 285. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY RETAIL & SPECIALTY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VACCINATION CENTERS & PUBLIC HEALTH AGENCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 287. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VACCINATION CENTERS & PUBLIC HEALTH AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 288. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VACCINATION CENTERS & PUBLIC HEALTH AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 289. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 290. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 291. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 292. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 293. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY BLOOD & PLASMA PRODUCTS, 2018-2032 (USD MILLION)
TABLE 294. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY CELL & GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 295. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY CLINICAL TRIAL MATERIALS, 2018-2032 (USD MILLION)
TABLE 296. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY INSULINS & HORMONES, 2018-2032 (USD MILLION)
TABLE 297. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY SPECIALTY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 298. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 299. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY PANDEMIC & EMERGING VACCINES, 2018-2032 (USD MILLION)
TABLE 300. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 301. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 302. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY CRYOGENIC (= -150 °C), 2018-2032 (USD MILLION)
TABLE 303. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY FROZEN (-20 TO -40 °C), 2018-2032 (USD MILLION)
TABLE 304. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED (2-8 °C), 2018-2032 (USD MILLION)
TABLE 305.

Companies Mentioned

The key companies profiled in this Cold-chain Pharma market report include:
  • Americold Realty Trust, Inc.
  • AmerisourceBergen Corporation
  • BioCold Technologies S.A.S
  • C.H. Robinson Worldwide, Inc.
  • Catalent, Inc.
  • Clinigen Group PLC
  • Conestoga Cold Storage Ltd.
  • Continental AG
  • CWT Ltd.
  • DB Schenker
  • DHL International GmbH
  • DSV A/S
  • Emergent Cold LatAm Management LLC
  • FedEx Corporation
  • FreezPak Logistics
  • HCL Technologies Limited
  • Helapet ltd.
  • Interstate Cold Storage, Inc.
  • JWD InfoLogistics Public Co. Ltd.
  • Keppel Telecommunications & Transportation Ltd,
  • Kerry Logistics Network Limited by SF Holding Co., Ltd.
  • Kuehne + Nagel Management AG
  • Lineage, Inc.
  • Mærsk A/S
  • NewCold Coöperatief UA
  • OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
  • SCG Logistics Management Co Ltd.
  • Tiong Nam Logistics Holdings Berhad
  • United Parcel Service, Inc.
  • Ych Group
  • Yusen Logistics Group

Table Information